Related Experiment Video
Updated: Jul 9, 2026

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion
1American Red Cross Blood Services, Southern California Region, Pomona, CA 91768, USA. garratty@usa.redcross.org
Producing universal group O red blood cells (RBCs) involves enzyme-converted (ECO) RBCs or polyethylene glycol (PEG)-modified RBCs. While ECO RBCs face cross-matching issues, PEG-RBCs raise concerns about immunogenicity and reduced survival, hindering their clinical use.
Area of Science:
- Blood banking and transfusion medicine
- Biotechnology and biomaterials
- Immunology
Background:
- Universal group O donor red blood cells (RBCs) are crucial for transfusions.
- Current methods for producing group O RBCs from other blood groups have limitations.
Purpose of the Study:
- To review and compare two main approaches for generating universal group O donor RBCs: enzyme-converted (ECO) RBCs and polyethylene glycol (PEG)-modified RBCs.
- To assess the challenges and potential of these methods for clinical application.
Main Methods:
- Enzyme-based conversion: Cleavage of terminal immunodominant sugars from RBC membranes using specific enzymes to create ECO RBCs.
- Chemical modification: Bonding polyethylene glycol (PEG) to RBCs to create 'stealth' PEG-RBCs that mask antigens.
Main Results:
- ECO RBCs from group B donors have been successfully transfused; however, group A RBC conversion presents difficulties, and polyclonal antibodies remain a cross-matching challenge.
- Initial 'stealth' PEG-RBCs showed in vitro serological issues and potential reduced in vivo survival. While improved, recent findings indicate PEG immunogenicity and antibody-mediated reduced survival of PEG-RBCs and pegylated proteins.
Conclusions:
- Enzyme-converted group O RBCs show promise but require further refinement to overcome cross-matching challenges with polyclonal antibodies.
- Polyethylene glycol-modified RBCs face significant hurdles due to immunogenicity and potential for reduced in vivo survival, questioning their future as 'stealth' RBCs.
More Related Videos
11:16Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...